HWG Holdings’s Integra LifeSciences IART Stock Holding History

HWG Holdings’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-42,366	Closed	-$2.31M	–	108
2017 Q2	$2.31M	Buy	+42,366	New	+$2.02M	1.71%	14

Other funds holding IART

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

HWG Holdings's IART Position: Q3 2017 in Review

HWG Holdings sold out of Integra LifeSciences (IART) in Q3 2017, closing a stake of 42,366 shares — an estimated $2.31M sold.

HWG Holdings first reported a position in IART in Q2 2017 and held it in 1 quarter. The position peaked at $2.31M in Q2 2017. 213 funds tracked by Wall St. Rank hold IART as of Q3 2017.

HWG Holdings reported no remaining Integra LifeSciences position as of Q3 2017 after selling out during the quarter.
HWG Holdings sold 42,366 Integra LifeSciences shares in Q3 2017, an estimated $2.31M.
HWG Holdings first reported a position in Integra LifeSciences in Q2 2017 and held it in 1 quarter.
HWG Holdings's Integra LifeSciences position peaked at $2.31M in Q2 2017.
213 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2017.

Based on HWG Holdings's 13F filing for Q3 2017, filed 14 Nov 2017.